Pfizer Limited Faces ₹87.90 Lakh GST Demand, Plans to Appeal

1738599795800.webp

Mumbai, February 3, 2025 – Pfizer Limited (NSE: PFIZER, BSE: 500680) has disclosed a tax demand and penalty totaling ₹87,90,380 imposed by the Assistant Commissioner, Central GST Division, Panchkula, Haryana under an order dated February 1, 2025.

Key Highlights of the Order:

  • Tax Demand: ₹43,95,190
  • Penalty: ₹43,95,190
  • Total Demand: ₹87,90,380
  • Order Reference: ZD0602250005900
  • Regulatory Basis: Sections 73(9)/74(9)/127/129(3)/130 of the CGST Act, 2017 and the Haryana GST Act, 2017.

Company’s Response and Legal Stand

Pfizer Limited stated that the demand was raised due to the alleged non-receipt of original duty-paying documentsfor verification by the tax authorities. However, the company clarified that it had already submitted photocopies of the necessary documents to the Central Tax Officer.

The company disputes the validity of the demand and has announced its intent to file an appeal against the order. Notably, Pfizer emphasized that the ruling has no material impact on its financials, operations, or other activities.

Outlook

While the tax demand does not impact Pfizer Limited’s core business operations, the outcome of the planned appealcould determine any future financial obligations. Investors and stakeholders will closely monitor any further legal developments in this matter.
 
Back
Top